249 related articles for article (PubMed ID: 12686661)
1. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity.
Stam F; van Guldener C; Schalkwijk CG; ter Wee PM; Donker AJ; Stehouwer CD
Nephrol Dial Transplant; 2003 May; 18(5):892-8. PubMed ID: 12686661
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.
Bolton CH; Downs LG; Victory JG; Dwight JF; Tomson CR; Mackness MI; Pinkney JH
Nephrol Dial Transplant; 2001 Jun; 16(6):1189-97. PubMed ID: 11390719
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
Stam F; van Guldener C; Becker A; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
J Am Soc Nephrol; 2006 Feb; 17(2):537-45. PubMed ID: 16382015
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.
Schalkwijk CG; Ter Wee PM; Stehouwer CD
Ann N Y Acad Sci; 2005 Jun; 1043():662-70. PubMed ID: 16037290
[TBL] [Abstract][Full Text] [Related]
6. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease.
Pannier B; Guerin AP; Marchais SJ; Metivier F; Safar ME; London GM
Kidney Int; 2000 Mar; 57(3):1091-9. PubMed ID: 10720961
[TBL] [Abstract][Full Text] [Related]
7. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients.
Aguilera A; Sánchez-Tomero JA; Bajo MA; Ruiz-Caravaca ML; Alvarez V; del Peso G; Herranz A; Cuesta MV; Castro MJ; Selgas R
Adv Perit Dial; 2003; 19():240-5. PubMed ID: 14763071
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.
Lieuw-A-Fa ML; van Hinsbergh VW; Teerlink T; Barto R; Twisk J; Stehouwer CD; Schalkwijk CG
Nephrol Dial Transplant; 2004 Mar; 19(3):631-6. PubMed ID: 14767019
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O
Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832
[TBL] [Abstract][Full Text] [Related]
10. The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis.
Mackinnon B; Deighan CJ; Norrie J; Boulton-Jones JM; Sattar N; Fox JG
Clin Nephrol; 2005 Mar; 63(3):173-80. PubMed ID: 15786817
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients.
Dong J; Li YJ; Yang ZK; Xu R
Perit Dial Int; 2014; 34(7):706-13. PubMed ID: 24584618
[TBL] [Abstract][Full Text] [Related]
12. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
[TBL] [Abstract][Full Text] [Related]
13. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
[TBL] [Abstract][Full Text] [Related]
14. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
[TBL] [Abstract][Full Text] [Related]
15. Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study.
Becker A; Van Hinsbergh VW; Kostense PJ; Jager A; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD
Eur J Clin Invest; 2000 Sep; 30(9):763-70. PubMed ID: 10998075
[TBL] [Abstract][Full Text] [Related]
16. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
Borawski J; Naumnik B; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
[TBL] [Abstract][Full Text] [Related]
18. Correlation between soluble markers of endothelial dysfunction in patients with renal failure.
Jacobson SH; Egberg N; Hylander B; Lundahl J
Am J Nephrol; 2002; 22(1):42-7. PubMed ID: 11919402
[TBL] [Abstract][Full Text] [Related]
19. Dietary proteins improve endothelial function under fasting conditions but not in the postprandial state, with no effects on markers of low-grade inflammation.
Teunissen-Beekman KF; Dopheide J; Geleijnse JM; Bakker SJ; Brink EJ; de Leeuw PW; Schalkwijk CG; van Baak MA
Br J Nutr; 2015 Dec; 114(11):1819-28. PubMed ID: 26400262
[TBL] [Abstract][Full Text] [Related]
20. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]